Executives

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a...

Acquisitions & Mergers

WELL Health Completes Acquisition of MyHealth

"We are delighted to be part of the entire WELL omni-channel patient services experience," said Suresh Madan, President and CEO of MyHealth.

Quipt Enters Four New States With Closings of Strategic Acquisitions

Quipt is undertaking an ongoing national expansion effort with the goal of economically growing its operating footprint to serve as a leader in respiratory homecare across the United States.

RAYUS Radiology Acquires InHealth Imaging to Expand Puget Sound Presence

National leader in radiology solutions, they continue to accelerate growth with three new Washington locations.

Boston Scientific Exercises Option to Acquire Farapulse, Inc.

FARAPULSE Pulsed Field Ablation (PFA) System is a non-thermal ablation system for the treatment of atrial fibrillation (AF) and other cardiac arrhythmias.  

Aspen Surgical Products Acquires Stork® Labor and Delivery Products

Founded in 1958, the Stork line of products includes high-quality, branded sterile disposable obstetric products.

Cano Health Acquires University Health Care for $600 Million and Increases 2021 Adjusted EBITDA Guidance to Over $100 Million

Company now projects full year 2021 adjusted EBITDA between $100 million and $110 million.

Growth & Development

Biospectal Raises $4.3M Seed Funding Led by Digital Health Investor, SeedLink

“Biospectal OptiBP is a breakthrough technology that enables more accessible, effective, and efficient patient monitoring to empower patients to contribute to, and participate in, the clinical regimen for chronic condition monitoring and management,” said Tim Juergens, General Manager, and co-founder, SeedLink.

R2 Technologies Receives Series C Investment of $15 Mil

The funds will be used to expand the company’s corporate footprint and US commercial acceleration of Glacial Rx™, its first-to-market revolutionary CryoAesthetic™ treatment, FDA-cleared to remove benign lesions and temporarily reduce pain, swelling and inflammation.

BIRD Foundation- Israel-U.S. Binational Industrial R&D Foundation to Invest $6 Mil in 6 New Projects

The approved projects involve innovations in the areas of Advanced Manufacturing, Communications, Cyber Security, Healthcare IT, Medical Devices, and others.